BioCentury | Feb 29, 2016
Finance

Full-spectrum investing

New investment firm Perceptive Bioscience Investments Ltd. is hoping its evergreen structure will give it the flexibility to find attractive valuations anywhere from seed-stage company formation to public equity. On Feb. 22, Perceptive launched with...
BC Week In Review | Jul 29, 2013
Company News

ReNeuron board of directors update

ReNeuron Group plc (LSE:RENE), Guildford, U.K.   Business: Neurology   Appointed: Sir Chris Evans, chairman of Arthurian Life Sciences  ...
BioCentury | Jul 29, 2013
Finance

Alive and Welsh

Alive and Welsh ReNeuron Group plc (LSE:RENE) is giving up a pound of flesh plus its Guildford, U.K., home base as part of last week's proposed financing. But to paraphrase George Rathmann, it's better to...
BC Extra | Jul 22, 2013
Financial News

ReNeuron to raise L25.4 million

ReNeuron Group plc (LSE:RENE) plans to raise L25.4 million ($38.7 million) in a placing of 1 billion shares at 2.5p to new investors Abingworth; Invesco; and the Wales Life Sciences Investment Fund. Existing investors and...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

BioCentury's 11th annual European Iceberg survey sees funding demand continue to fall for a shrinking number of public clinical-stage biotechs in Europe, while the capital demanded by the growing cadre of venture biotechs continues to...
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

Wale(s) of experience A group of seasoned life science investors, academics and former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences . The group's first task is...
Items per page:
1 - 6 of 6
BioCentury | Feb 29, 2016
Finance

Full-spectrum investing

New investment firm Perceptive Bioscience Investments Ltd. is hoping its evergreen structure will give it the flexibility to find attractive valuations anywhere from seed-stage company formation to public equity. On Feb. 22, Perceptive launched with...
BC Week In Review | Jul 29, 2013
Company News

ReNeuron board of directors update

ReNeuron Group plc (LSE:RENE), Guildford, U.K.   Business: Neurology   Appointed: Sir Chris Evans, chairman of Arthurian Life Sciences  ...
BioCentury | Jul 29, 2013
Finance

Alive and Welsh

Alive and Welsh ReNeuron Group plc (LSE:RENE) is giving up a pound of flesh plus its Guildford, U.K., home base as part of last week's proposed financing. But to paraphrase George Rathmann, it's better to...
BC Extra | Jul 22, 2013
Financial News

ReNeuron to raise L25.4 million

ReNeuron Group plc (LSE:RENE) plans to raise L25.4 million ($38.7 million) in a placing of 1 billion shares at 2.5p to new investors Abingworth; Invesco; and the Wales Life Sciences Investment Fund. Existing investors and...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

BioCentury's 11th annual European Iceberg survey sees funding demand continue to fall for a shrinking number of public clinical-stage biotechs in Europe, while the capital demanded by the growing cadre of venture biotechs continues to...
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

Wale(s) of experience A group of seasoned life science investors, academics and former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences . The group's first task is...
Items per page:
1 - 6 of 6